Latest Novartis Stories
Could psychoactive drugs such as LSD be an effective treatment for alcoholism and depression? One UK professor believes so, and he’s asking for your help in funding his research.
DALLAS and NEW YORK, March 5, 2015 /PRNewswire/ -- PlasmaTech Biopharmaceuticals, Inc.
COSENTYX(TM) (secukinumab), recently FDA-approved to treat plaque psoriasis, will be available for patients through the nation's largest independent specialty pharmacy. FLINT,
BASEL, Switzerland, March 3, 2015 /PRNewswire/ -- Syngenta announced today the successful issue of a EUR 500 million Eurobond with a maturity of 121/2 years and a coupon
LONDON, March 3, 2015 /PRNewswire/ -- Report Details Vaccines and their technology - your guide to developments, opportunities and revenues See what the future
- Array to receive $85 million upfront payment from Novartis - BOULDER, Colo., March 2, 2015 /PRNewswire/ -- Following announcements from both Novartis and GlaxoSmithKline regarding
Exemplary companies and organizations to be honored March 3 during 2015 ASAP Global Alliance Summit for outstanding partnering, alliance programs, and collaboration efforts ranging from combatting
CRANFIELD, England, February 26, 2015 /PRNewswire/ -- Now in its fifth year, the Productive Innovation Index (PII) celebrates the top 30 pharmaceutical companies most successful
- The governor of a province or people.